Do analysts rate BCPC or IOSP?

Balchem presently has a consensus target price of $176.00, indicating a potential upside of 11.55%. Given Balchem's stronger consensus rating and higher probable upside, equities research analysts clearly believe Balchem is more favorable than Innospec. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Balchem 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00 Innospec 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has preferable earnings & valuation, BCPC or IOSP?

Balchem has higher earnings, but lower revenue than Innospec. Innospec is trading at a lower price-to-earnings ratio than Balchem, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Balchem $1.04B 4.89 $154.85M $4.87 32.40 Innospec $1.78B 1.12 $116.60M $4.59 17.67

Is BCPC or IOSP more profitable?

Balchem has a net margin of 14.95% compared to Innospec's net margin of 6.38%. Balchem's return on equity of 13.38% beat Innospec's return on equity. Company Net Margins Return on Equity Return on Assets Balchem 14.95% 13.38% 10.17% Innospec 6.38% 9.32% 6.79%

Which has higher valuation and earnings, FUL or BCPC?

Balchem has lower revenue, but higher earnings than H. B. Fuller. H. B. Fuller is trading at a lower price-to-earnings ratio than Balchem, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio H. B. Fuller $3.47B 0.98 $151.97M $3.03 20.67 Balchem $1.04B 4.89 $154.85M $4.87 32.40

Is FUL or BCPC more profitable?

Balchem has a net margin of 14.95% compared to H. B. Fuller's net margin of 4.62%. Balchem's return on equity of 13.38% beat H. B. Fuller's return on equity. Company Net Margins Return on Equity Return on Assets H. B. Fuller 4.62% 11.84% 4.52% Balchem 14.95% 13.38% 10.17%

Does the media prefer FUL or BCPC?

In the previous week, H. B. Fuller had 9 more articles in the media than Balchem. MarketBeat recorded 11 mentions for H. B. Fuller and 2 mentions for Balchem. Balchem's average media sentiment score of 0.88 beat H. B. Fuller's score of 0.63 indicating that Balchem is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment H. B. Fuller 3 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Balchem 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation & earnings, GGG or BCPC?

Graco has higher revenue and earnings than Balchem. Graco is trading at a lower price-to-earnings ratio than Balchem, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Graco $2.25B 5.49 $521.84M $3.07 24.21 Balchem $1.04B 4.89 $154.85M $4.87 32.40

Is GGG or BCPC more profitable?

Graco has a net margin of 22.96% compared to Balchem's net margin of 14.95%. Graco's return on equity of 18.66% beat Balchem's return on equity. Company Net Margins Return on Equity Return on Assets Graco 22.96% 18.66% 15.22% Balchem 14.95% 13.38% 10.17%

Does the media favor GGG or BCPC?

In the previous week, Graco and Graco both had 2 articles in the media. Balchem's average media sentiment score of 0.88 beat Graco's score of 0.60 indicating that Balchem is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Graco 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Balchem 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation & earnings, BCPC or ITW?

Illinois Tool Works has higher revenue and earnings than Balchem. Illinois Tool Works is trading at a lower price-to-earnings ratio than Balchem, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Balchem $1.04B 4.89 $154.85M $4.87 32.40 Illinois Tool Works $16.04B 4.51 $3.07B $10.77 23.33

Does the media prefer BCPC or ITW?

In the previous week, Illinois Tool Works had 8 more articles in the media than Balchem. MarketBeat recorded 10 mentions for Illinois Tool Works and 2 mentions for Balchem. Illinois Tool Works' average media sentiment score of 1.32 beat Balchem's score of 0.88 indicating that Illinois Tool Works is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Balchem 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Illinois Tool Works 7 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation & earnings, BCPC or ALB?

Balchem has higher earnings, but lower revenue than Albemarle. Albemarle is trading at a lower price-to-earnings ratio than Balchem, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Balchem $1.04B 4.89 $154.85M $4.87 32.40 Albemarle $5.14B 3.88 -$510.63M -$3.41 N/A

Is BCPC or ALB more profitable?

Balchem has a net margin of 14.95% compared to Albemarle's net margin of -5.00%. Balchem's return on equity of 13.38% beat Albemarle's return on equity. Company Net Margins Return on Equity Return on Assets Balchem 14.95% 13.38% 10.17% Albemarle -5.00% 5.22% 2.51%

Does the media favor BCPC or ALB?

In the previous week, Albemarle had 6 more articles in the media than Balchem. MarketBeat recorded 8 mentions for Albemarle and 2 mentions for Balchem. Albemarle's average media sentiment score of 1.38 beat Balchem's score of 0.88 indicating that Albemarle is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Balchem 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Albemarle 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Balchem (BCPC) Competitors

$157.51 +0.20 (+0.13%)

As of 12:26 PM Eastern

Compare

BCPC vs. IOSP, FUL, GGG, ITW, and ALB

Should you buy Balchem stock or one of its competitors? MarketBeat compares Balchem with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Balchem include Innospec (IOSP), H. B. Fuller (FUL), Graco (GGG), Illinois Tool Works (ITW), and Albemarle (ALB).

How does Balchem compare to Innospec?

Balchem (NASDAQ:BCPC) and Innospec (NASDAQ:IOSP) are both basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, media sentiment, risk, dividends, earnings and institutional ownership.

Balchem has higher earnings, but lower revenue than Innospec. Innospec is trading at a lower price-to-earnings ratio than Balchem, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Balchem	$1.04B	4.89	$154.85M	$4.87	32.40
Innospec	$1.78B	1.12	$116.60M	$4.59	17.67

Balchem has a beta of 0.82, indicating that its share price is 18% less volatile than the broader market. Comparatively, Innospec has a beta of 0.92, indicating that its share price is 8% less volatile than the broader market.

Balchem presently has a consensus target price of $176.00, indicating a potential upside of 11.55%. Given Balchem's stronger consensus rating and higher probable upside, equities research analysts clearly believe Balchem is more favorable than Innospec.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Balchem	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.00
Innospec	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Balchem has a net margin of 14.95% compared to Innospec's net margin of 6.38%. Balchem's return on equity of 13.38% beat Innospec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Balchem	14.95%	13.38%	10.17%
Innospec	6.38%	9.32%	6.79%

In the previous week, Balchem had 1 more articles in the media than Innospec. MarketBeat recorded 2 mentions for Balchem and 1 mentions for Innospec. Innospec's average media sentiment score of 1.78 beat Balchem's score of 0.88 indicating that Innospec is being referred to more favorably in the news media.

Company	Overall Sentiment
Balchem	Positive
Innospec	Very Positive

87.9% of Balchem shares are owned by institutional investors. Comparatively, 96.6% of Innospec shares are owned by institutional investors. 1.7% of Balchem shares are owned by insiders. Comparatively, 1.5% of Innospec shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Balchem pays an annual dividend of $0.96 per share and has a dividend yield of 0.6%. Innospec pays an annual dividend of $1.84 per share and has a dividend yield of 2.3%. Balchem pays out 19.7% of its earnings in the form of a dividend. Innospec pays out 40.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Balchem has raised its dividend for 16 consecutive years and Innospec has raised its dividend for 11 consecutive years.

Summary

Balchem beats Innospec on 15 of the 20 factors compared between the two stocks.

How does Balchem compare to H. B. Fuller?

H. B. Fuller (NYSE:FUL) and Balchem (NASDAQ:BCPC) are both mid-cap basic materials companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, valuation, earnings, media sentiment, institutional ownership and profitability.

H. B. Fuller currently has a consensus price target of $63.80, indicating a potential upside of 1.85%. Balchem has a consensus price target of $176.00, indicating a potential upside of 11.55%. Given Balchem's stronger consensus rating and higher possible upside, analysts plainly believe Balchem is more favorable than H. B. Fuller.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
H. B. Fuller	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.71
Balchem	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.00

H. B. Fuller pays an annual dividend of $0.98 per share and has a dividend yield of 1.6%. Balchem pays an annual dividend of $0.96 per share and has a dividend yield of 0.6%. H. B. Fuller pays out 32.3% of its earnings in the form of a dividend. Balchem pays out 19.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. H. B. Fuller has increased its dividend for 57 consecutive years and Balchem has increased its dividend for 16 consecutive years. H. B. Fuller is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

95.9% of H. B. Fuller shares are held by institutional investors. Comparatively, 87.9% of Balchem shares are held by institutional investors. 1.8% of H. B. Fuller shares are held by company insiders. Comparatively, 1.7% of Balchem shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Balchem has a net margin of 14.95% compared to H. B. Fuller's net margin of 4.62%. Balchem's return on equity of 13.38% beat H. B. Fuller's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
H. B. Fuller	4.62%	11.84%	4.52%
Balchem	14.95%	13.38%	10.17%

In the previous week, H. B. Fuller had 9 more articles in the media than Balchem. MarketBeat recorded 11 mentions for H. B. Fuller and 2 mentions for Balchem. Balchem's average media sentiment score of 0.88 beat H. B. Fuller's score of 0.63 indicating that Balchem is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
H. B. Fuller	3 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Balchem	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Balchem has lower revenue, but higher earnings than H. B. Fuller. H. B. Fuller is trading at a lower price-to-earnings ratio than Balchem, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
H. B. Fuller	$3.47B	0.98	$151.97M	$3.03	20.67
Balchem	$1.04B	4.89	$154.85M	$4.87	32.40

H. B. Fuller has a beta of 0.96, indicating that its share price is 4% less volatile than the broader market. Comparatively, Balchem has a beta of 0.82, indicating that its share price is 18% less volatile than the broader market.

Summary

Balchem beats H. B. Fuller on 11 of the 19 factors compared between the two stocks.

How does Balchem compare to Graco?

Graco (NYSE:GGG) and Balchem (NASDAQ:BCPC) are related companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings, media sentiment and risk.

Graco has a beta of 0.93, indicating that its share price is 7% less volatile than the broader market. Comparatively, Balchem has a beta of 0.82, indicating that its share price is 18% less volatile than the broader market.

Graco pays an annual dividend of $1.18 per share and has a dividend yield of 1.6%. Balchem pays an annual dividend of $0.96 per share and has a dividend yield of 0.6%. Graco pays out 38.4% of its earnings in the form of a dividend. Balchem pays out 19.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Graco has increased its dividend for 29 consecutive years and Balchem has increased its dividend for 16 consecutive years. Graco is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Graco has higher revenue and earnings than Balchem. Graco is trading at a lower price-to-earnings ratio than Balchem, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Graco	$2.25B	5.49	$521.84M	$3.07	24.21
Balchem	$1.04B	4.89	$154.85M	$4.87	32.40

93.9% of Graco shares are owned by institutional investors. Comparatively, 87.9% of Balchem shares are owned by institutional investors. 2.2% of Graco shares are owned by company insiders. Comparatively, 1.7% of Balchem shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Graco has a net margin of 22.96% compared to Balchem's net margin of 14.95%. Graco's return on equity of 18.66% beat Balchem's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Graco	22.96%	18.66%	15.22%
Balchem	14.95%	13.38%	10.17%

Graco presently has a consensus target price of $94.25, suggesting a potential upside of 26.82%. Balchem has a consensus target price of $176.00, suggesting a potential upside of 11.55%. Given Graco's higher possible upside, analysts plainly believe Graco is more favorable than Balchem.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Graco	0 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.43
Balchem	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.00

In the previous week, Graco and Graco both had 2 articles in the media. Balchem's average media sentiment score of 0.88 beat Graco's score of 0.60 indicating that Balchem is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Graco	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Balchem	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Graco beats Balchem on 13 of the 19 factors compared between the two stocks.

How does Balchem compare to Illinois Tool Works?

Balchem (NASDAQ:BCPC) and Illinois Tool Works (NYSE:ITW) are related companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability.

87.9% of Balchem shares are held by institutional investors. Comparatively, 79.8% of Illinois Tool Works shares are held by institutional investors. 1.7% of Balchem shares are held by insiders. Comparatively, 0.8% of Illinois Tool Works shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Illinois Tool Works has higher revenue and earnings than Balchem. Illinois Tool Works is trading at a lower price-to-earnings ratio than Balchem, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Balchem	$1.04B	4.89	$154.85M	$4.87	32.40
Illinois Tool Works	$16.04B	4.51	$3.07B	$10.77	23.33

Balchem pays an annual dividend of $0.96 per share and has a dividend yield of 0.6%. Illinois Tool Works pays an annual dividend of $6.44 per share and has a dividend yield of 2.6%. Balchem pays out 19.7% of its earnings in the form of a dividend. Illinois Tool Works pays out 59.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Balchem has increased its dividend for 16 consecutive years and Illinois Tool Works has increased its dividend for 55 consecutive years. Illinois Tool Works is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Balchem presently has a consensus target price of $176.00, indicating a potential upside of 11.55%. Illinois Tool Works has a consensus target price of $271.92, indicating a potential upside of 8.21%. Given Balchem's stronger consensus rating and higher possible upside, research analysts plainly believe Balchem is more favorable than Illinois Tool Works.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Balchem	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.00
Illinois Tool Works	5 Sell rating(s)	7 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.69

Illinois Tool Works has a net margin of 19.32% compared to Balchem's net margin of 14.95%. Illinois Tool Works' return on equity of 97.36% beat Balchem's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Balchem	14.95%	13.38%	10.17%
Illinois Tool Works	19.32%	97.36%	19.41%

Balchem has a beta of 0.82, indicating that its stock price is 18% less volatile than the broader market. Comparatively, Illinois Tool Works has a beta of 1.01, indicating that its stock price is 1% more volatile than the broader market.

In the previous week, Illinois Tool Works had 8 more articles in the media than Balchem. MarketBeat recorded 10 mentions for Illinois Tool Works and 2 mentions for Balchem. Illinois Tool Works' average media sentiment score of 1.32 beat Balchem's score of 0.88 indicating that Illinois Tool Works is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Balchem	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Illinois Tool Works	7 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Illinois Tool Works beats Balchem on 11 of the 20 factors compared between the two stocks.

How does Balchem compare to Albemarle?

Balchem (NASDAQ:BCPC) and Albemarle (NYSE:ALB) are both basic materials companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, earnings, profitability, valuation, institutional ownership and risk.

Balchem pays an annual dividend of $0.96 per share and has a dividend yield of 0.6%. Albemarle pays an annual dividend of $1.62 per share and has a dividend yield of 1.0%. Balchem pays out 19.7% of its earnings in the form of a dividend. Albemarle pays out -47.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Balchem has raised its dividend for 16 consecutive years and Albemarle has raised its dividend for 30 consecutive years. Albemarle is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Balchem presently has a consensus price target of $176.00, indicating a potential upside of 11.55%. Albemarle has a consensus price target of $203.04, indicating a potential upside of 19.88%. Given Albemarle's higher probable upside, analysts plainly believe Albemarle is more favorable than Balchem.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Balchem	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.00
Albemarle	1 Sell rating(s)	11 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.56

Balchem has a beta of 0.82, meaning that its stock price is 18% less volatile than the broader market. Comparatively, Albemarle has a beta of 1.3, meaning that its stock price is 30% more volatile than the broader market.

Balchem has higher earnings, but lower revenue than Albemarle. Albemarle is trading at a lower price-to-earnings ratio than Balchem, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Balchem	$1.04B	4.89	$154.85M	$4.87	32.40
Albemarle	$5.14B	3.88	-$510.63M	-$3.41	N/A

Balchem has a net margin of 14.95% compared to Albemarle's net margin of -5.00%. Balchem's return on equity of 13.38% beat Albemarle's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Balchem	14.95%	13.38%	10.17%
Albemarle	-5.00%	5.22%	2.51%

In the previous week, Albemarle had 6 more articles in the media than Balchem. MarketBeat recorded 8 mentions for Albemarle and 2 mentions for Balchem. Albemarle's average media sentiment score of 1.38 beat Balchem's score of 0.88 indicating that Albemarle is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Balchem	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Albemarle	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

87.9% of Balchem shares are held by institutional investors. Comparatively, 92.9% of Albemarle shares are held by institutional investors. 1.7% of Balchem shares are held by insiders. Comparatively, 0.4% of Albemarle shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Albemarle beats Balchem on 10 of the 19 factors compared between the two stocks.

Get Balchem News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BCPC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BCPC vs. The Competition

Export

Metric	Balchem	CHEM Industry	Materials Sector	NASDAQ Exchange
Market Cap	$5.07B	$15.10B	$4.93B	$12.49B
Dividend Yield	0.61%	1.95%	4.95%	5.30%
P/E Ratio	32.40	35.12	23.53	24.34
Price / Sales	4.89	2.48	6,540.70	125.86
Price / Cash	23.70	14.56	27.35	57.88
Price / Book	4.06	4.71	9.49	6.76
Net Income	$154.85M	$376.44M	$156.62M	$337.09M
7 Day Performance	-1.96%	-1.59%	0.77%	1.50%
1 Month Performance	-2.32%	-1.61%	1.48%	6.18%
1 Year Performance	-5.32%	20.33%	71.16%	35.62%

Balchem Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BCPC Balchem	3.1618 of 5 stars	$157.20 -0.1%	$176.00 +12.0%	-5.1%	$5.05B	$1.04B	32.28	1,352
IOSP Innospec	4.3526 of 5 stars	$82.29 +0.4%	N/A	-4.1%	$2.02B	$1.78B	17.93	2,450	Positive News
FUL H. B. Fuller	4.8356 of 5 stars	$62.08 +2.5%	$63.80 +2.8%	+14.1%	$3.30B	$3.47B	20.49	7,100
GGG Graco	4.8498 of 5 stars	$76.11 -0.3%	$94.25 +23.8%	-11.7%	$12.67B	$2.24B	24.79	4,400
ITW Illinois Tool Works	4.0408 of 5 stars	$250.65 +0.1%	$271.92 +8.5%	+2.6%	$72.04B	$16.04B	23.27	43,000	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BCPC) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Balchem (BCPC) Competitors